Application 761436

Type
BLA
Sponsor
BIOCON BIOLOGICS INC

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761436Bosayadenosumab-kyqq351(k) InterchangeableRx2026-06-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001AUKELSODENOSUMAB-KYQQINJECTABLE;INJECTION120MG/1.7ML(70MG/ML)NoNo
002BOSAYADENOSUMAB-KYQQINJECTABLE;INJECTION60MG/MLNoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
AUKELSODENOSUMAB-KYQQBiocon Biologics Inc.547cb095-f7f5-f933-75ce-5e6abf2ad5bc2026-03-27Warnings, Adverse reactionsExact identifier
application number: BLA761436
BOSAYADENOSUMAB-KYQQBiocon Biologics Inc.1e5e8c88-3c65-3076-e44b-02d92c2d343d2026-03-27Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA761436

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84349ORIG 2025-12-08
84348ORIG 2025-12-08
84021ORIG 2025-10-31
84020ORIG 2025-10-31
84011ORIG 2025-10-31
83379ORIG 2025-09-18
83372ORIG 2025-09-17
83371ORIG 2025-09-17